Emd Serono Inc Drug Patent Portfolio

Emd Serono Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Emd Serono Inc News

FDA broadens labeling for Novartis and Roche's popular drug, transforms EMD Serono's treatment for non-small cell lung cancer ...

16 Feb, 2024

See More